Sleep Disorders Trial, Recruiting NCT05209438 Sponsor: Wake Forest University Health Sciences Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05209438
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who provide at least 10 hours of caregiving per week (any type of caregiving counts)
  • People who are willing to give their informed consent to participate
  • People who are able to follow basic instructions
  • People who are able to sit comfortably for up to 90 minutes and attend up to three 60-minute sessions per week over a 4-week period
  • People who report experiencing stress, anxiety, or sleep problems, and whose symptoms reach a certain level on at least one of the study's standard questionnaires (confirm with trial site for exact score thresholds)

Who may not be able to join:

  • People who provide fewer than 10 hours of caregiving per week
  • People who are unable or unwilling to attend the sessions during the study period
  • People who are unable or unwilling to give their consent to participate
  • People who are not experiencing symptoms of stress, anxiety, or insomnia
  • People with a hearing impairment severe enough that they cannot hear tones through earbuds
  • People with a known seizure disorder, or who have had thoughts of suicide in the last 3 months
  • People who weigh more than 400 pounds (due to the weight limit of the chair used in the study)
  • People who are currently taking part in another intervention study
  • People who have used the specific technology being tested in this trial within the past 3 years
  • People who have used certain brain or nervous system therapies — such as neurofeedback, biofeedback, deep brain stimulation, EMDR, electroconvulsive therapy, or similar treatments — within the last month
  • People with a pacemaker, or who take medications (such as beta blockers) that may affect heart rate measurements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Charles Tegeler, MD, Wake Forest University Health Sciences

Phone: 336-716-9447

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 June 2022
Est. completion
1 July 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Blood Pressure Measurements; Change in Heart Rate (HR); Change in Heart Rate Variability (HRV); Change in Baroreflex Sensitivity; Blood Pressure Variability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov